2006
DOI: 10.1176/ajp.2006.163.7.1208
|View full text |Cite
|
Sign up to set email alerts
|

Family Focused Grief Therapy: A Randomized, Controlled Trial in Palliative Care and Bereavement

Abstract: Family focused grief therapy has the potential to prevent pathological grief. Benefit is clear for intermediate and sullen families. Care is needed to avoid increasing conflict in hostile families.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
207
0
12

Year Published

2008
2008
2017
2017

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 168 publications
(222 citation statements)
references
References 38 publications
3
207
0
12
Order By: Relevance
“…A Terapia Familiar Focada no Luto (TFFL; Family Focused Grief Therapy), proposta por Kissane e Bloch (2002), assenta numa perspetiva sistémica e familiar e está devidamente validada, através de estudos de eficácia que comprovam a pertinência da sua aplicação junto das famílias em cuidados paliativos (Kissane et al, 2006).…”
Section: A Terapia Familiar Focada No Lutounclassified
See 3 more Smart Citations
“…A Terapia Familiar Focada no Luto (TFFL; Family Focused Grief Therapy), proposta por Kissane e Bloch (2002), assenta numa perspetiva sistémica e familiar e está devidamente validada, através de estudos de eficácia que comprovam a pertinência da sua aplicação junto das famílias em cuidados paliativos (Kissane et al, 2006).…”
Section: A Terapia Familiar Focada No Lutounclassified
“…Por isso, enquanto abordagem profilática, a TFFL é proposta apenas às famílias que apresentem um padrão de funcionamento desajustado (Kissane & Bloch, 2002;Kissane et al, 2006;Schuler, Zaider, & Kissane, 2012).…”
Section: A Terapia Familiar Focada No Lutounclassified
See 2 more Smart Citations
“…A few studies commented in detail on the barriers to recruitment including the degree of patient illness; a lack of interest in the study purpose; lack of perceived benefit from the study; fear from harm in study participation; insufficient time; demographic and socioeconomic factors; and negative referring clinician attitudes [4,6,11,12,18].…”
Section: The Literature Reviewmentioning
confidence: 99%